The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...
With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.
From heart disease to neurodegeneration, Novartis makes bold deals in 2025 to expand its drug pipeline globally.
The global biotech industry is booming, and by 2025 it will reach an estimated market worth of $729B. But while great innovation is driven by emerging biotechs, these companies often lack resources, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback